Life Matters

A pre-clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis (CF).

Health Tech & Life Sciences
Active
Pre-Funding Rehovot, Israel
Website ↗
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
Headcount
5
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

Life Matters Israel is a privately held, pre-clinical-stage biopharmaceutical company headquartered in Rehovot, Israel. The company is dedicated to significantly improving the lives of people with cystic fibrosis (CF). Life Matters develops a New Modality to fight resistant bacteria, often found in the lungs of CF patients, by signaling the bacteria to remain in the planktonic mode rather than entering into the biofilm mode. This approach aims to make infections more treatable, leading to an improvement in how the disease is managed. Their lead API, IBF-2, is a first-of-its-kind compound with an innovative mechanism of action that can attenuate the biofilm mode of growth, a crucial phenotype allowing bacteria to survive environmental stresses. The company emphasizes that its small molecules have superiority over common traditional antibiotics as they do not possess any selection pressure towards the bacteria, a resistance-creating mechanism. Their compounds also have broad activity against various gram-negative and positive pathogens.

Q&A

What is Life Matters' primary focus?
Life Matters is a preclinical-stage biopharmaceutical company focused on tackling antibiotic-resistant bacteria by preventing biofilm growth, particularly in hospital-acquired infections.
What is the company's lead product?
Life Matters' lead product is API, IBF-2, a compound designed to attenuate the biofilm mode of growth, which helps bacteria survive environmental stresses and immune responses.
When was Life Matters founded?
Life Matters was founded in July 2016.
How many employees does Life Matters have?
Life Matters has 1-10 employees.
What is Life Matters' current funding stage?
Life Matters is currently in the Pre-Funding stage.
Who are the co-founders of Life Matters?
The co-founders of Life Matters are Amit Elbaz (CEO), Prof. Robert S. Marks (Scientific Advisor), Karina Golberg (Inventor & Chief Research Officer), and Prof. Ariel Kushmaro (Inventor & Scientific Advisor).
Where is Life Matters headquartered?
Life Matters is headquartered in Jerusalem, Israel.
What is the primary sector of Life Matters?
Life Matters operates in the Health Tech & Life Sciences sector.

Team · 1

Prof. Robert S. Marks
Founder · Co-founder & Scientific Advisor

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicesbiotechnologypharmaceuticalshospitalspharma-companiesbiopharmaceuticalimmunologytherapeuticsventilationrespiratorylife-sciencespulmonaryinfectious-diseasebacteriaanimal-health
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitelifematters.co.il/

Identifiers & details

Employees (exact)5
OfficesHatsav

Radar intelligence

Open jobs — smartrecruiters

Total open2
Remote0
By locationFalls Church, VA, us (1), Sterling, VA, us (1)
TitleLocationDepartment
Certified Nursing AssistantsFalls Church, VA, us
Certified Nursing AssistantsSterling, VA, us

Patents

EPO3

Web history (Wayback)

Domainlifematters.co.il

Certificate / subdomain footprint

Subdomains0

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515588804
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2017-01-16
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2023
Active charges / liens0
Registry events1 — violation (1)
Registered address461 חצב

Recent registry events

DateEvent
2026-06-25עדכון הפרה